Summary: Zevra Therapeutics Inc., in its yr-conclude fiscal and corporate update for 2023, highlighted the development of KP1077 in dealing with idiopathic hypersomnia, citing promising Stage 2 analyze final results. The organization also introduced designs to existing new info … [Read more...]
Health Canada Approves Wakix for Pediatric Narcolepsy Patients
Wakix is the 1st Well being Canada-approved cure for youngsters 6 decades of age and older suffering from excessive daytime sleepiness or cataplexy indicators connected with narcolepsy. Paladin Labs Inc, a subsidiary of Endo International plc, announced Overall health Canada’s … [Read more...]
AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial
Summary: In the SYMPHONY stage 3 trial, Axsome Therapeutics’ AXS-12 considerably lowered weekly cataplexy assaults and improved indications of narcolepsy, which include extreme daytime sleepiness, cognitive operate, and over-all ailment severity, when compared to placebo. The … [Read more...]
Survey Sheds Light on Narcolepsy Treatment Challenges
Summary: Axsome Therapeutics, in collaboration with Narcolepsy Network, performed the CRESCENDO study, revealing ongoing problems faced by narcolepsy sufferers inspite of cure. The examine associated 203 grownup people diagnosed with narcolepsy form 1, highlighting persistent … [Read more...]